TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
出版年份 2018 全文链接
标题
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
作者
关键词
-
出版物
OncoImmunology
Volume 7, Issue 7, Pages e1442999
出版商
Informa UK Limited
发表日期
2018-02-21
DOI
10.1080/2162402x.2018.1442999
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Colorectal cancer prevention: Immune modulation taking the stage
- (2018) Rochelle Fletcher et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes
- (2018) David S Williams et al. GUT
- Evolving notions on immune response in colorectal cancer and their implications for biomarker development
- (2018) Fabio Grizzi et al. INFLAMMATION RESEARCH
- Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer
- (2018) Meenakshi Rajpoot et al. SEMINARS IN CANCER BIOLOGY
- Colorectal Cancers: An Update on Their Molecular Pathology
- (2018) Kentaro Inamura Cancers
- Immunotherapy for colorectal cancer: where are we heading?
- (2017) Debora Basile et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status
- (2017) Tsuyoshi Hamada et al. JOURNAL OF CLINICAL ONCOLOGY
- Wnt/beta-catenin pathway: modulating anticancer immune response
- (2017) Sachin Gopalkrishna Pai et al. Journal of Hematology & Oncology
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Implications of the tumor immune microenvironment for staging and therapeutics
- (2017) Janis M Taube et al. MODERN PATHOLOGY
- Bioactive Nutrients and Nutrigenomics in Age-Related Diseases
- (2017) Tania Rescigno et al. MOLECULES
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- Molecular subtypes in cancers of the gastrointestinal tract
- (2017) Maarten F. Bijlsma et al. Nature Reviews Gastroenterology & Hepatology
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma
- (2017) Takeharu Ono et al. Oncotarget
- Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
- (2017) Jiwon Koh et al. Oncotarget
- PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer
- (2017) Taisuke Yagi et al. ANNALS OF SURGERY
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
- (2016) C.-Y. Ock et al. CLINICAL CANCER RESEARCH
- Tumour CD274 (PD-L1) expression and T cells in colorectal cancer
- (2016) Yohei Masugi et al. GUT
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors
- (2016) Ryan Gentzler et al. Immunotherapy
- Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis
- (2016) Tsuyoshi Hamada et al. JOURNAL OF GASTROENTEROLOGY
- Tumor-Infiltrating Lymphocytes, Crohn’s-Like Lymphoid Reaction, and Survival From Colorectal Cancer
- (2016) Laura S. Rozek et al. JNCI-Journal of the National Cancer Institute
- PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
- (2016) Matthew W Rosenbaum et al. MODERN PATHOLOGY
- From tumour heterogeneity to advances in precision treatment of colorectal cancer
- (2016) Cornelis J. A. Punt et al. Nature Reviews Clinical Oncology
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored
- (2016) Stephen K.H. Li et al. TRENDS IN MOLECULAR MEDICINE
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
- (2016) Marios Giannakis et al. Cell Reports
- NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets
- (2016) Morten Nielsen et al. Genome Medicine
- Tumor-Infiltrating Lymphocytes, Crohn’s-Like Lymphoid Reaction, and Survival From Colorectal Cancer
- (2016) Laura S. Rozek et al. JNCI-Journal of the National Cancer Institute
- Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
- (2016) Kosuke Mima et al. Clinical and Translational Gastroenterology
- Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy
- (2016) Yu Zhang et al. JAMA Oncology
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Immune Therapy in GI Malignancies: A Review
- (2015) Judy Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
- (2015) Annie A Wu et al. OncoImmunology
- Inducible Expression of B7-H1 (PD-L1) and Its Selective Role in Tumor Site Immune Modulation
- (2014) Miguel F. Sanmamed et al. CANCER JOURNAL
- Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review
- (2014) Yu Imamura et al. Molecular Cancer
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
- (2014) T. Bald et al. Cancer Discovery
- Radiation and immunotherapy: a synergistic combination
- (2013) Anusha Kalbasi et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
- (2013) Reiko Nishihara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
- (2012) Mai Yamauchi et al. GUT
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
- (2011) R. R. Huang et al. CLINICAL CANCER RESEARCH
- Association of CTNNB1 (β-Catenin) Alterations, Body Mass Index, and Physical Activity With Survival in Patients With Colorectal Cancer
- (2011) Teppei Morikawa JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
- (2010) S. Ogino et al. GUT
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
- (2010) Katsuhiko Nosho et al. JOURNAL OF PATHOLOGY
- Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- (2008) S. Ogino et al. GUT
- Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample
- (2008) Katsuhiko Nosho et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now